Medicare Enrolled
Dr. Jason Peter, D.O.
Pain Medicine · Troy, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Peter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peter
Dr. Jason Peter is a pain medicine specialist in Troy, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Peter performed 3,701 Medicare services across 1,346 unique beneficiaries.
Between the years covered by Open Payments, Dr. Peter received a total of $22,868 from 50 pharmaceutical and/or device companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 10% volume in MI
$22,868 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,701
Medicare services
Top 10% in MI for pain medicine
1,346
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~206 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,020 | $91 | $200 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
485 | $194 | $596 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
278 | $61 | $186 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
260 | $0 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
139 | $67 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $119 | $375 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
81 | $104 | $1,002 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
52 | $47 | $750 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
50 | $68 | $650 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
49 | $40 | $625 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
33 | $81 | $1,150 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
29 | $153 | $470 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
18 | $87 | $1,100 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
17 | $93 | $1,235 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
17 | $111 | $1,360 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
17 | $63 | $1,000 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
17 | $233 | $2,880 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
17 | $72 | $1,440 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,868
Total received (2018-2024)
Avg $3,267/year across 7 years
Top 0% in MI for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
500
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,868 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,009
2023
$3,012
2022
$3,664
2021
$4,210
2020
$3,136
2019
$4,590
2018
$3,247
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$343
Collegium Pharmaceutical, Inc.
$162
SPR Therapeutics, Inc
$135
Medtronic, Inc.
$86
Stryker Corporation
$63
Vertos Medical, Inc.
$57
Nevro Corp.
$34
Spinal Simplicity, LLC
$30
Abbott Laboratories
$24
Saluda Medical Americas, Inc.
$21
ANI Pharmaceuticals, Inc.
$20
SI-BONE, INC.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 63.5% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$5,079
Medtronic, Inc.
$4,365
Abbott Laboratories
$2,667
Vertiflex, Inc.
$1,628
Relievant Medsystems, Inc.
$1,478
Medtronic USA, Inc.
$1,272
Boston Scientific Corporation
$931
Vertos Medical, Inc.
$763
SPR Therapeutics, Inc
$696
Collegium Pharmaceutical, Inc.
$576
Stimwave Technologies Incorporated
$444
PFIZER INC.
$392
BOSTON SCIENTIFIC CORPORATION
$382
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$263
Spinal Simplicity, LLC
$210
Daiichi Sankyo Inc.
$182
UCB, Inc.
$125
Indivior Inc.
$103
Stryker Corporation
$96
Nalu Medical, Inc.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$86
Horizon Therapeutics plc
$85
Almatica Pharma LLC
$76
Amgen Inc.
$67
Sentynl Therapeutics, Inc.
$66
Scilex Pharmaceuticals Inc.
$62
Virtus Pharmaceuticals LLC
$61
Purdue Pharma L.P.
$58
Vertical Pharmaceuticals, LLC
$47
Nuvectra Corporation
$47
Lilly USA, LLC
$46
Jazz Pharmaceuticals Inc.
$42
FIDIA PHARMA USA INC.
$40
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$39
Egalet US Inc
$30
AstraZeneca Pharmaceuticals LP
$28
PAINTEQ LLC
$26
Flexion Therapeutics, Inc.
$23
Azurity Pharmaceuticals, Inc.
$21
Saluda Medical Americas, Inc.
$21
ANI Pharmaceuticals, Inc.
$20
Bioventus LLC
$20
Biohaven Pharmaceutical Holding Company Ltd.
$18
SI-BONE, INC.
$17
Assertio Therapeutics, Inc.
$16
Teva Pharmaceuticals USA, Inc.
$14
Orexo US, Inc.
$13
RedHill Biopharma Inc.
$13
Horizon Pharma plc
$13
Kaleo, Inc.
$12
Top 3 companies account for 53.0% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AJOVY · ASCENDA · Accurian · Aimovig · Algovita · Amitiza · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · Belbuca · DRG IPGs · DUEXIS · Durolane · EMGALITY · ETERNA · Evoke · Evzio · FLECTOR · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRAFTON · GRALISE · General - Pain Management · HA MINUTEMAN G3-R · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN 2RF · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · MAGNIFUSE · MILD DEVICE KIT · MOVANTIK · Morphabond ER · Movantik · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PURIFIED CORTROPHIN GEL · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · RELISTOR · RELISTOR ORAL · RESTORE · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBLOCADE · SUPERION · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · Superion · Superion ISS · VIMOVO · WaveWriter Alpha Prime 16 · XIFIXAN · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zubsolv · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 0% for pain medicine in MI.
Geographic Context
Pain medicines within 10 mi
13
Per 100K population
1.0
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL, TROY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Peter is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MI), with low-engagement industry engagement in the top 0% of MI peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Peter experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Peter performed 2,020 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peter receive payments from pharmaceutical companies?
Yes. Dr. Peter received a total of $22,868 from 50 companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peter's costs compare to other pain medicines in Troy?
Dr. Peter's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Troy
Browse pain medicines in Troy ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in MI
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in MI
Which MI pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology